Virchow Group
Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Efficacy, Safety and Pharmacokinetic of Virchow IVIG in PID Patients
- Conditions
- Primary Immunodeficiency Diseases (PID)
- Interventions
- Drug: IVIG-VImmuneDrug: IVIG-Immuglo
- First Posted Date
- 2025-06-12
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Virchow Group
- Target Recruit Count
- 44
- Registration Number
- NCT07017036
- Locations
- 🇮🇳
All India Institute of Medical Sciences, Nagpur, Maharastra, India
🇮🇳Jyoti Nursing Home (P) Ltd., Jaipur, Rajasthan, India
Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer
- Conditions
- Diabetic Foot Ulcers
- Interventions
- Drug: Biochaperone PDGF-BB High doseDrug: Biochaperone PDGF-BB Very Low DoseDrug: Biochaperone PDGF-BB Low dose
- First Posted Date
- 2010-04-02
- Last Posted Date
- 2014-12-15
- Lead Sponsor
- Virchow Group
- Target Recruit Count
- 192
- Registration Number
- NCT01098357
- Locations
- 🇮🇳
Vijay Vachharajani Memorial, Rajkot, Gujarat, India
🇮🇳Jain Institute of Vascular sciences, Bangalore, Karnataka, India
🇮🇳Karnataka Institute of Diabetology, Bangalore, Karnataka, India
Safety and Efficacy of TULY (Rasburicase) in Prevention and Treatment of Malignancy-associated Hyperuricemia
- First Posted Date
- 2009-06-16
- Last Posted Date
- 2014-12-12
- Lead Sponsor
- Virchow Group
- Target Recruit Count
- 100
- Registration Number
- NCT00921375
- Locations
- 🇮🇳
Dr. Raghunathrao, Hyd, Andhra Pradesh, India
Safety and Efficacy of OSTEOFORM (rhPTH [1-34]) in Increasing Bone Mineral Density in Osteoporosis
- Conditions
- Osteoporosis
- Interventions
- Drug: OsteoformDrug: SHELCAL
- First Posted Date
- 2007-07-12
- Last Posted Date
- 2014-12-16
- Lead Sponsor
- Virchow Group
- Target Recruit Count
- 82
- Registration Number
- NCT00500409
- Locations
- 🇮🇳
Apollo Hospitals, Chennai, Tamil Nadu, India
🇮🇳CARE Hospitals, Hyderabaad, Andhra Pradesh, India
🇮🇳Medwin Hospital, Hyderabaad, Andhra Pradesh, India
Efficacy and Safety of PERIOGEN in the Treatment of Periodontal Bone Defect
- Conditions
- Intrabony Periodontal Defect
- Interventions
- Drug: Beta TCP alone
- First Posted Date
- 2007-07-04
- Last Posted Date
- 2014-12-16
- Lead Sponsor
- Virchow Group
- Target Recruit Count
- 60
- Registration Number
- NCT00496847
- Locations
- 🇮🇳
Sri Sai Dental college of surgery, Vikarabad,, RR Dist, Andhra pradesh, India